The below content is purely factual and information-based. It’s purpose is to allow patients to access and download the consumer medicines information (CMI) for their specific product. Lumir is a prescription-only cannabis medication. To find out more about the process of getting a prescription, click here.
To find out what ailments Medical Cannabis can treat, the Australian Therapeutic Goods Administrations (TGA) has published guidance documents on their website.
You can use the EVA app to help you monitor impact your medication is having on your symptoms. This simple to use app can help you and your doctor better understand how you react to your Cannabis medication and respond accordingly with appropriate dosing and formulation recommendations.
Lumir Medical Cannabis products are not registered on the ARTG and have not been assessed for their safety or efficacy. They are not subsidized by Medicare and are only available in Australia through the Special Access Scheme.